samedan logo
 
 
spacer
home > pmps > spring 2002 > branding in the pharmaceutical industry
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Branding in the Pharmaceutical Industry

The global pharmaceutical industry is undergoing profound change, and pharmaceutical companies - traditionally science and sales-driven businesses - must embrace marketing and branding strategies to a much greater extent than they have done in the past. Brand building during the period a new drug remains under patent can help prolong the commercial life of the product once its monopoly status lapses. And strongly branded prescription drugs can make the transition into the over-the-counter (OTC) arena more easily. The role and value of branding in the pharmaceutical industry is changing.

Branding has barely existed in the pharmaceutical industry, yet the word 'brand' is used indiscriminately and, largely, inaccurately. Branding is the act of finding a trademark for a new product, launching it into the marketplace, advertising it, and then giving up all support when the patent lapses.

In the world of consumer goods and services, companies have used branding techniques to achieve competitive advantage for decades. Such techniques involve the development of a set of distinguishing characteristics in the product (or service), which are capable of having a strong and distinctive impression on the customer. If this impression is positive and other factors are in place - typically price and availability - then a purchase decision that favours the brand will generally arise.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Tom Blackett, Group Deputy Chairman of Interbrand Tom Blackett joined Interbrand in 1983. He held the position of Managing Director of the company's London business from 1985 to 1989, and was appointed Group Deputy Chairman in 1996. Experienced in all areas of the company's work, he has handled projects for major international brand owners such as Heineken, British Telecom, Unilever, Glaxo Wellcome, BP Amoco and Volvo.
Prior to joining Interbrand, Tom worked for five years with Inbucon Management Consultants as a Research Director in their marketing division. This followed five years with Research International - then Unilever's market research subsidiary - and three years with Attwood Statistics, another leading market research firm. Tom has written and co-written many books on branding.

spacer
Tom Blackett
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

FT Global Pharmaceutical and Biotechnology Conference 2008

2-3 December 2008, The Cumberland, London

FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >>

 
News and Press Releases

“PACK DIFFERENT” with EMBALLAGE 2008

“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement